Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-923-5 | CAS number: 10305-39-2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- 21 November 2019 - 17 December 2019
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Justification for type of information:
- In the interest of sound science and animal welfare, a sequential testing strategy is recommended to minimise the need of in vivo testing. One of the validated in vitro skin sensitization tests is the h-CLAT test, which is recommended in international guidelines (e.g. OECD).
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 020
- Report date:
- 2020
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: OECD 442E In vitro skin sensitisation: human cell line activation test (h-CLAT)
- Version / remarks:
- 2017
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- activation of dendritic cells
- Justification for non-LLNA method:
- The purpose of this study was to evaluate the ability of Saskine 70 to activate the dendritic cells. Activation of these cells can lead to skin sensitisation.
Test material
- Reference substance name:
- 3-(heptyloxy)propane-1,2-diol
- Cas Number:
- 10305-39-2
- Molecular formula:
- C10H22O3
- IUPAC Name:
- 3-(heptyloxy)propane-1,2-diol
- Test material form:
- liquid: viscous
- Details on test material:
- Colour: Clear to yellow
Storage temperature: Room temperature (20°C ± 5°C)
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: Room temperature, protected from light
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: Test substance was dissolved in DMSO. Highest concentration: 500 mg/mL (stock solution). Compound concentration in the wroking solution (culture medium) 1000 µg/mL
In vitro test system
- Details on the study design:
- CONTROLS
Vehicle control: DMSO
REFERENCE ITEMS
Dinitrochlorobenzene (DNCB)
Concentration: 4 µg/mL in DMSO
CAS: 97-00-7
Nickel sulfate (NiSO4)
Concentration: 100 µg/mL in PBS
CAS: 10101-97-0
Lactic acid (LA)
Concentration: 1000 µg/mL in 0.9% NaCl
CAS: 50-21-5
TEST SYSTEM
Cell type: THP-1 cells
Source: American type culture collection
Batch: 61077351
Culture conditions: 37 °C, 5% CO2, humidified atmosphere
Culture medium: RPMI-1640, supplemented with 10% Foetal calf serum, 100 units/mL penicillin and 100 µg/ml streptomycin.
Seeding densitiy for testing: 0.2 x E6* (pre-cultured for 72 hours)
*The cell seeding specifications have been modified from the protocol outlined in the guidelines. However, the protocol has been established and validated by Eurosafe as the density is optimal in this condition not exceeding 1 x E6 cells/mL after amplification.
CYTOTOXICITY ASSAYS
Eight concentrations of test item were prepared by a two-fold serial dilution from a maximum final concentration of 1000 µg/mL or lower, depending on its solubility limit.
On the day of testing, cells were harvested and suspended in fresh culture medium at 2 x E6 cells/mL. Then, THP-1 cells were distributed into a 24 well flat-bottom plate with 500 µL (1 x E6 cells/well) with various concentrations of test item for 24 ± 0.5 hours at 37 °C. After incubation, cells were stained with 7-AAD (5 µg/mL) and analysed with flow cytometry to measure cell viability.
Log CV75 = ((75-c) x Log (b) - (75-a) x Log (d))/(a-c)
a = minimum value of cell viability over 75%
c = maximum value of cell viability below 75%
b and d are the concentrations showing the value of cell viability a and c respectively.
ACTIVATION TEST
Each activation test was performed on eight concentrations: 25.1, 30.1, 36.2, 43.4, 52.1, 62.5, 75.0, 90 µg/mL
Top concentration was considered to be be the limit of cytotoxicity based on the cell toxicity assays.
THP-1 cells were plated at 1 X E6 cells/mL/well in 24 well plates and treated for 24 ± 0.5 hours at 37 °C ± under 5 ± 1% CO2. After treatment cells were washed twice with Fb buffer. After washing, blocking the cells with Fb buffer containing 0.01% (w/v) globulin was not performed due to low expression of Fc receptors by THP-1 cells.
Cells were stained for 30 min at 4 °C with the following antibodies: anti-human CD54, anti-human CD86, fluorescein isothiocyanate (FITC) labelled-mouse IgG1 using the manufacturer's recommended dilutions. Then, the cells were stained with 7-AAD for at least 30 min at 4 °C. After washing once and resuspension with Fb, Fluorescence intensities of the THP-1 cell surface markers were analysed by flow cytometry on 10000 living cells.
DATA ANALYSIS AND INTERPRETATION
Relative fluorescence intensity (RFI):
RFI = ((MFI of test item treated cells - MFI of test item treated isotype control cells) / (MFI of vehicle control cells - MFI of vehicle isotype control cells)) x 100
MFI: mean fluorescence intensity
Effective concentration (EF):
EC150 (CD86) = Bconcentration + ((150 - BRFI)/(ARFI-BRFI) x (Aconcentration - Bconcentration))
EC200 (CD54) = Bconcentration + ((200 - BRFI)/(ARFI-BRFI) x (Aconcentration - Bconcentration))
Aconcentration: lowest concentration in µg/mL, with RFI > 150 (CD86) or 200 (CD54)
Bconcentration: highest concentration in µg/mL, with RFI < 150 (CD86) or 200 (CD54)
ARFI: RFI at the lowest concentration with RFI > 150 (CD86) or 200 (CD54)
BRFI: RFI at the highest cncentration with RFI < 150 (CD86) or 200 (CD54)
ACCEPTACE CRITERIA
- In the positive control (DNCB) (performed in all activation experiments) and (NiS04) (performed only in an activation experiment): RFI values of both CD86 and CD54 must be over the positive criteria (CD54 ≥ 200% and CD86 ≥ 150%). The cell viability must be more than 50%.
- In the negative control (LA) {performed only in an activation experiment): RFI values of both CD86 and CD54 must be under the positive criteria (CD54 < 200% and CD86 < 150%). The cell viability must be more than 50%.
- In the vehicle control(medium, 0.9% NaCI, DMSO, Ethanoletc.): Cell viability must be more than 90%. In the solvent/vehicle control, RFI values of both CD86 and CD54 must not exceed the positive criteria (CD86 ≥ 150% and CD54 ≥ 200%) compared to the medium control. The MFI ratio of both CD86 and CD54 to isotype control must be > 105%.
- In the test item: Cell viability must be more than 50% in at least four tested concentrations in each run.
EVALUATION CRITERIA
The positive criteria are described as following:
RFI of CD54 ≥ 200% and/or RFI of CD86 ≥ 150% of their respective control, at any tested concentration.
Results and discussion
- Positive control results:
- Experiment 2 (cell viability ≥ 70%):
- CD54: RFI (%) = 1913
- CD86: RFI (%) = 383
Experiment 3 (cell viability ≥ 70%):
- CD54: RFI (%) = 790
- CD86: RFI (%)= 460
In vitro / in chemico
Resultsopen allclose all
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: RFI (%)
- Remarks:
- CD86
- Value:
- 96
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Top dose: 90.0 µg/mL; RFI: 96 %
- Key result
- Run / experiment:
- other: 2
- Parameter:
- other: RFI (%)
- Remarks:
- CD86
- Value:
- 90
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Top dose: 90.0 µg/mL; RFI: 140%
- Key result
- Run / experiment:
- other: 1
- Parameter:
- other: RFI (%)
- Remarks:
- CD54
- Value:
- 141
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Top dose: 90.0 µg/mL; RFI: 162%
- Key result
- Run / experiment:
- other: 2
- Parameter:
- other: RFI (%)
- Remarks:
- CD54
- Value:
- 120
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Remarks:
- Top dose: 90.0 µg/mL; RFI: 180%
- Other effects / acceptance of results:
- - Cytotoxicity was induced on THP-1 cells by Saskine 70. According to this cytotoxic profile CV75: 74.1 μg/mL
- One deviation was observed in experiment 1 with a RFI value of CD86 > 150% for the DMSO control.
ACCEPTANCE CRITERIA
- In the positive control (DNCB) RFI values were above the criteria in experiment 2 and 3 (CD54: 1913 and 383; CD86: 383 and 460).
- In the negative control (LA) (performed only in an activation experiment): RFI values of both CD86 and CD54 were under the positive criteria (CD54: 136 and CD86: 59). The cell viability was 98%.
- In the vehicle control (DMSO): Cell viability was ≥ 97%. In the solvent/vehicle control, RFI values of CD86 was 124 and 100 in experiment 2 and 3 and the RFI values of CD54 were 123 and 123 in experiment 2 and 3 (CD86 ≥ 150% and CD54 ≥ 200%) compared to the medium control. The MFI ratio of both CD86 and CD54 to isotype control must be > 105% (198 and 127, respectively).
- In the test item: Cell viability was more than 50% in at least four tested concentrations in each run.
Applicant's summary and conclusion
- Interpretation of results:
- other: Study can be part of a weight of evidence
- Conclusions:
- In a h-CLAT test performed according to OECD TG 442E and in accordance with GLP principles, Saskine 70 did not activate dendritic cells and therefore tested negative for skin sensitizing properties under experimental conditions described in this report.
- Executive summary:
A h-CLAT test was performed with Saskine 70 according to OECD guideline 442E and in accordance with GLP principles. The study consisted of two seperate experiments. Based on the solvent, negative and positive controls it was concluded that the test conditions were adequate and that the test system functioned properly. Cell viability (CV) was determined to be 75% at a concentration of 74.1 μg/mL. In both experiments, all concentrations tested did not induce a 1.5 or 2-fold increase of CD86 and CD54, respectively. Based on the results, Saskine 70 is not considered to have skin sensitizing properties under the current experimental conditions.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.